glp 1 and papillary thyroid cancer Do GLP-1 Medications Cause Cancer? UK Evidence Safety Guidance – Bolt Pharmacy Glucagon-like peptide-1 medicines and cancer

Use point-of-care gastric ultrasound when feasible to assess for retained gastric contents

The rising use of these treatments in patients without diabetes has increased demand and raised questions about access for those with diabetes and obesity

Starting GLP-1 therapy only to stop it two months before trying to conceive may not provide a long enough treatment window to achieve meaningful results

Building a long-term partnership with your prescriber Your first appointment is not the finish line

Weight loss does improve certain PCOS symptoms, per a 2024 systematic review in Annals of Internal Medicine , but again, its extra tricky for those with the under-researched condition